| 000 | 01424 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513214621.0 | ||
| 264 | 0 | _c20000905 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0008-6363 | ||
| 024 | 7 |
_a10.1016/s0008-6363(00)00042-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaron, J H | |
| 245 | 0 | 0 |
_aIn vitro evaluation of c7E3-Fab (ReoPro) eluting polymer-coated coronary stents. _h[electronic resource] |
| 260 |
_bCardiovascular research _cJun 2000 |
||
| 300 |
_a585-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAbsorption |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aBinding Sites, Antibody |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xprevention & control |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aStents |
| 700 | 1 | _aGershlick, A H | |
| 700 | 1 | _aHogrefe, K | |
| 700 | 1 | _aArmstrong, J | |
| 700 | 1 | _aHolt, C M | |
| 700 | 1 | _aAggarwal, R K | |
| 700 | 1 | _aAzrin, M | |
| 700 | 1 | _aEzekowitz, M | |
| 700 | 1 | _ade Bono, D P | |
| 773 | 0 |
_tCardiovascular research _gvol. 46 _gno. 3 _gp. 585-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0008-6363(00)00042-0 _zAvailable from publisher's website |
| 999 |
_c10862264 _d10862264 |
||